Our Experts

Amish Chaturvedi

Senior Director – Asia Pacific

Amish Chaturvedi is an experienced market access professional with extensive experience in developing and delivering pricing, market access and reimbursement strategies, integrated evidence planning to support HTA. He has worked on Access to Medicine policy across regions and at a country level. In a career spanning 22 years he has worked across multiple therapy areas including Oncology, Immunology, Neuroscience, Infectious Diseases and Vaccines. ​

Prior to joining EVERSANA, Amish spent 15 years in the industry working as therapy area lead for market access, reimbursement, pricing and policy for Medicines Australia, Abbvie and Janssen (J&J) at a country and regional level. Amish has hands-on experience managing reimbursement submissions to NICE,SMC and AWMSG in the UK. He has a deep understanding of key Asia Pacific markets and their HTA requirements (JP, AU, NZ, SK and TW).

Amish excels in developing market access, pricing and reimbursement strategies, optimizing evidence from a HTA perspective for pipeline assets, shaping policy at therapy area level and influencing broader access policies to support launch readiness and HTA success. In addition, Amish helps clients optimize their access and reimbursement strategies at a regional level (EU and APAC) and frame HTA submissions at country level.

Amish holds a B-Pharm degree, Master of Business Administration degree (Australian National University) and Health Economics degree from London School of Economics (LSE).